PURE BIOSCIENCE, INC.

PURE

PURE BIOSCIENCE, INC.

PURE

Insider Sentiment (TTM):

Last Purchase:2023-03-22Last Sale:2020-12-19Shares Purchased (TTM):0Shares Sold (TTM):0

Institutional Sentiment:

As of:2022-09-30Institutional Shares Owned:809,809Shares Outstanding:111,356,473Institutional Ownership Pct.:0.73%

Earnings Market Reaction:

Filing Date:2026-06-15Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-04-30	2026-01-31	2025-10-31	2025-07-31	2025-04-30	2025-01-31	2024-10-31	2024-07-31	2024-04-30	2024-01-31	2023-10-31	2023-07-31
Assets
Assets Current
Cash And Cash Equivalents At Carrying Value	1	0	0	0	1	0	0	0	0	1	1	1
Accounts Receivable Net Current	0	0	0	0	0	0	0	0	0	0	0	0
Inventory Net	0	0	0	0	0	0	0	0	0	0	0	0
Restricted Cash And Cash Equivalents	-	-	-	-	-	-	0	0	0	0	0	0
Restricted Cash Current	0	0	0	0	0	0	-	0	-	-	-	-
Prepaid Expense Current	0	0	0	0	0	0	0	0	0	0	0	0
Assets Current	2	1	1	1	1	1	1	1	1	1	2	2
Property Plant And Equipment Net	0	0	0	0	0	0	0	0	0	0	0	0
Assets	2	1	1	1	1	1	1	1	1	1	2	2
Liabilities And Stockhold…
Liabilities Current
Accounts Payable Current	1	1	1	1	1	1	1	1	1	0	1	0
Convertible Notes Payable Current	3	-	-	-	-	-	-	-	-	-	-	-
Accrued Liabilities Current	0	0	0	0	0	0	0	0	0	0	0	0
Liabilities Current	4	3	3	1	1	1	1	1	1	1	1	1
Liabilities Noncurrent
Long Term Notes Payable	-	-	-	-	-	-	-	-	-	-	-	1
Liabilities Noncurrent	-	-	-	-	-	4	4	3	2	2	2	1
Convertible Long Term Notes Payable	4	-	-	-	-	-	-	-	-	-	-	-
Liabilities	7	7	7	6	6	5	4	4	3	2	3	2
Stockholders Equity
Common Stock Value	1	1	1	1	1	1	1	1	1	1	1	1
Additional Paid In Capital	134	133	133	133	133	133	133	133	133	133	132	132
Retained Earnings Accumulated Deficit	-141	-140	-139	-139	-139	-138	-137	-137	-136	-135	-134	-133
Stockholders Equity	-6	-6	-6	-5	-5	-4	-3	-3	-2	-1	-0	0
Liabilities And Stockholders Equity	2	1	1	1	1	1	1	1	1	1	2	2
Preferred Stock Par Or Stated Value Per Share	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01
Preferred Stock Shares Authorized	5	5	5	5	5	5	5	5	5	5	5	5
Preferred Stock Shares Issued	0	0	0	0	0	0	0	0	0	0	0	0
Preferred Stock Shares Outstanding	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Par Or Stated Value Per Share	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01
Common Stock Shares Authorized	200	200	200	200	200	200	200	200	150	150	150	200
Common Stock Shares Issued	130	112	112	112	112	112	112	112	112	112	112	112
Shares Outstanding	130	112	112	112	112	112	112	112	112	112	112	112

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	0.00%	0.00%	20.00%	0.00%	-12.50%	-12.50%	-14.29%	-	-	-	-	-
2025	33.33%	16.67%	-16.67%	-14.29%	-14.29%	57.14%	0.00%	0.00%	12.50%	-37.50%	-37.50%	-37.50%
2024	-12.50%	-43.75%	-43.75%	-11.11%	11.11%	-11.11%	0.00%	0.00%	-14.29%	22.22%	0.00%	-11.11%
2023	-	-	-	-	-	-	-	-	-	20.00%	30.00%	30.00%
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 90+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Start free trial

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics	2026-04-30	2026-01-31	2025-10-31	2025-07-31	2025-04-30	2025-01-31	2024-10-31	2024-07-31	2024-04-30	2024-01-31	2023-10-31	2023-07-31
Liquidity Ratios
Current Ratio	0.42	0.25	0.37	1.12	1.08	0.65	1.00	1.10	1.30	1.72	2.56	3.02
Quick Ratio	0.36	0.17	0.28	0.94	0.93	0.53	0.87	0.98	1.13	1.47	2.31	2.73
Working Capital	-2.11M	-2.28M	-1.98M	109.00K	74.00K	-304.00K	0.00	72.00K	203.00K	394.00K	1.26M	1.07M
Leverage & Debt
Debt to Equity	-1.27	-1.13	-1.21	-1.21	-1.22	-1.13	-1.26	-1.29	-1.43	-1.82	-6.87	5.71
Interest Coverage TTM	-4.91	-5.48	-6.11	-7.60	-10.06	-12.75	-16.10	-20.59	-31.68	-49.64	-101.89	-281.64
Debt Ratio	4.75	8.96	5.68	5.84	5.55	8.43	4.78	4.50	3.33	2.22	1.17	0.85
Efficiency & Turnover
Asset Turnover TTM	1.85	3.53	2.23	2.35	1.93	2.24	1.13	1.49	1.52	1.14	0.72	0.60
Days Sales Outstanding TTM	39.86	32.75	58.92	63.98	49.73	34.40	72.92	54.20	36.83	29.01	51.37	47.25
Receivables Turnover TTM	9.16	11.14	6.19	5.70	7.34	10.61	5.01	6.73	9.91	12.58	7.11	7.72
Per Share Metrics
Diluted EPS TTM	-0.02	-0.02	-0.02	-0.02	-0.03	-0.03	-0.03	-0.03	-0.03	-0.03	-0.03	-0.04
Free Cash Flow Per Share TTM	-0.02	-0.02	-0.02	-0.02	-0.02	-0.02	-0.02	-0.02	-0.02	-0.03	-0.03	-0.03
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Margin Metrics
Gross Profit Margin TTM	58.84%	59.78%	60.66%	59.17%	58.05%	58.27%	57.60%	58.69%	57.29%	55.23%	54.32%	51.73%
Operating Profit Margin TTM	-79.11%	-82.34%	-85.98%	-103.18%	-137.81%	-154.03%	-172.90%	-162.56%	-168.15%	-173.75%	-172.37%	-210.07%
Net Profit Margin TTM	-91.04%	-89.78%	-92.35%	-108.95%	-147.65%	-166.49%	-183.86%	-170.66%	-173.41%	-177.20%	-174.01%	-211.03%
Growth Metrics
Net Revenue Growth (1Y)	26.67%	29.27%	31.00%	12.18%	-8.56%	-9.48%	-15.55%	4.58%	23.95%	14.02%	16.73%	1.30%
Net Income Growth (1Y)	-21.89%	-30.29%	-34.20%	-28.39%	-22.15%	-14.95%	-10.78%	-15.43%	-12.88%	-9.91%	0.41%	13.46%
EPS Growth (1Y)	-21.17%	-30.31%	-34.22%	-28.39%	-22.15%	-14.95%	-10.78%	-15.77%	-13.27%	-10.31%	-0.04%	-9.52%
Valuation Metrics
P/E TTM	-3.52	-2.59	-3.60	-4.20	-2.38	-2.53	-3.05	-2.67	-2.16	-3.38	-2.42	-2.53
P/B TTM	-1.33	-0.89	-1.41	-1.97	-1.39	-1.84	-2.88	-3.12	-3.65	-9.31	-23.36	36.86
P/S TTM	3.20	2.32	3.33	4.57	3.51	4.21	5.60	4.56	3.74	5.98	4.21	5.34
Market Cap	7.76M	5.59M	7.83M	10.07M	6.71M	7.83M	10.07M	8.95M	7.83M	12.30M	8.95M	10.03M
Enterprise Value	13.27M	5.40M	7.40M	9.73M	6.17M	7.55M	9.72M	8.52M	7.31M	11.67M	7.51M	9.88M
Calculated Values
Free Cash Flow TTM	-1.78M	-1.82M	-1.76M	-2.02M	-2.15M	-2.26M	-2.59M	-2.53M	-2.73M	-2.81M	-2.90M	-3.40M
Net Debt	5.51M	-198.00K	-434.00K	-334.00K	-540.00K	-277.00K	-346.00K	-424.00K	-517.00K	-632.00K	-1.44M	-149.00K
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
PEG Ratio
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
EV Revenue TTM
EV FCF TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2023-03-22Purchase

Owner: Bartlett, Robert F

Title: CEO

Shares: 50,000

Price/Share: $0.16

Value: $8,000.00

Shares Owned: 50,000

Relationship: Director,Officer

Ownership: Indirect

2023-03-21Purchase

Owner: Blotner, Bernard

Title: -

Shares: 10,000

Price/Share: $0.13

Value: $1,300.00

Shares Owned: 10,000

Relationship: Director

Ownership: Indirect

2022-12-15Purchase

Owner: Lee, Tom Y

Title: Chief Executive Officer

Shares: 50,000

Price/Share: $0.13

Value: $6,500.00

Shares Owned: 5,001,843

Relationship: Director,Officer,TenPercentOwner

Ownership: Direct

2022-03-21Purchase

Owner: Lee, Tom Y

Title: Chief Executive Officer

Shares: 185,000

Price/Share: $0.20

Value: $37,000.00

Shares Owned: 4,951,843

Relationship: Director,Officer,TenPercentOwner

Ownership: Direct

2021-06-16Purchase

Owner: Lee, Tom Y

Title: Chief Executive Officer

Shares: 35,998

Price/Share: $0.43

Value: $15,479.14

Shares Owned: 4,732,366

Relationship: Director,Officer

Ownership: Direct

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2023-03-22	Bartlett, Robert F	Director,Officer	CEO	Indirect	Purchase	50,000	0.16	$8,000.00	50,000	4
2023-03-21	Blotner, Bernard	Director	-	Indirect	Purchase	10,000	0.13	$1,300.00	10,000	4
2022-12-15	Lee, Tom Y	Director,Officer,TenPercentOwner	Chief Executive Officer	Direct	Purchase	50,000	0.13	$6,500.00	5,001,843	4
2022-03-21	Lee, Tom Y	Director,Officer,TenPercentOwner	Chief Executive Officer	Direct	Purchase	185,000	0.20	$37,000.00	4,951,843	4
2021-06-16	Lee, Tom Y	Director,Officer	Chief Executive Officer	Direct	Purchase	35,998	0.43	$15,479.14	4,732,366	4
2020-12-24	Lee, Tom Y	Director,Officer	Chief Executive Officer	Direct	Purchase	851	0.65	$553.15	4,696,368	4
2020-12-19	Okuno, Dale	Director	-	Direct	Sale	748,880	0.29	$217,175.20	5,560,540	4
2020-06-22	Lee, Tom Y	Director,Officer	Chief Executive Officer	Direct	Purchase	13,124	1.72	$22,573.28	4,617,647	4
2020-06-17	Lee, Tom Y	Director,Officer	Chief Executive Officer	Direct	Purchase	26,876	1.61	$43,270.36	4,564,523	4
Additional insider transactions are for subscribers only. Unlock the complete Form 4 filing history Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2022-09-30

0.73%

Inst. Shares: 809,809

Shares Outstanding: 111,356,473

2021-12-31

0.02%

Inst. Shares: 13,830

Shares Outstanding: 87,873,141

2021-09-30

0.02%

Inst. Shares: 13,830

Shares Outstanding: 87,432,380

2021-06-30

0.02%

Inst. Shares: 13,830

Shares Outstanding: 87,174,312

2021-03-31

0.02%

Inst. Shares: 13,830

Shares Outstanding: 87,223,141

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2022-09-30	809,809	111,356,473	0.73%
2021-12-31	13,830	87,873,141	0.02%
2021-09-30	13,830	87,432,380	0.02%
2021-06-30	13,830	87,174,312	0.02%
2021-03-31	13,830	87,223,141	0.02%
2020-09-30	13,830	82,209,487	0.02%
2020-06-30	13,830	82,209,487	0.02%
2020-03-31	7,760	83,979,076	0.01%
2019-12-31	7,794	79,994,402	0.01%
Additional institutional holders are for subscribers only. Unlock the complete Form 13F ownership history Start 7-day free trial

PURE BIOSCIENCE, INC. (PURE) — SEC Financial Statements & Analysis

PURE BIOSCIENCE, INC. (PURE) is a miscellaneous chemical products company, incorporated in DE. PURE BIOSCIENCE, INC. trades on OTC as: PURE. Based on its latest SEC filing (Form 10-Q, period ending 2026-04-30), PURE BIOSCIENCE, INC. reported a 26.67% year-over-year revenue growth, a Gross Profit Margin of 58.84% (TTM), a Debt-to-Equity ratio of -1.27x, a Price-to-Sales (P/S) ratio of 3.20x (TTM), a Price-to-Book (P/B) ratio of -1.33x (TTM), at a market cap of $7.76M. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y: 26.67%
Gross Profit Margin TTM: 58.84%
Debt To Equity: -1.27x
P/S TTM: 3.20x
P/B TTM: -1.33x
Market Cap: $7.76M

Data as of 2026-04-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is PURE BIOSCIENCE, INC. in?

PURE BIOSCIENCE, INC. (PURE) operates in the Miscellaneous Chemical Products industry.

What is PURE's market cap?

PURE BIOSCIENCE, INC. (PURE) has a market capitalization of $7.76M as of 2026-04-30.

What exchange does PURE trade on?

PURE BIOSCIENCE, INC. (PURE) trades on the OTC.

Where is PURE BIOSCIENCE, INC. incorporated?

PURE BIOSCIENCE, INC. is incorporated in DE.